Literature DB >> 11819329

Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma.

Wen-Liang Wang, Guang-Yu Gu, Min Hu.   

Abstract

AIM:To explore the etiology and pathogenesis of human primary intrahepatic cholangiocarcinoma, the expression of HBV genes and HBV-antigens was detected in the cancerous tissue and its surrounding hepatic tissues.
METHODS: HBV-antigens were detected by immunohistochemical technique and HBV genes were examined with in situ hybridization.
RESULTS: In 20 cases of cholangiocarcinoma, the positive detection rate of HBxAg, pre-S1, pre-S2, HBsAg and HBcAg was 75%, 40%, 40%, 10% and 0%, respectively, and in the surrounding hepatic tissues of 19 cases the positive rates were 84.2%, 47.9%, 47.9%, 31.6% and 31.6%.Among 40 cases of cholangiocarcinoma, the positive rate of HBV-DNA, x-gene, pre-s gene, s gene and s gene fell on 77.5%, 70.0%, 47.5%, 40% and 42.5%, respectively,and of the surrounding hepatic tissues in 33 cases, 87.9%, 84.8%, 63.6%, 69.7% and 66.7%.
CONCLUSION: The development of human primary intrahepatic cholangiocarcinoma bears a close relationship with chronic persistent HBV infection. Particularly,the x gene of HBV and its protein (HBxAg) might play an important role in pathogenesis of hepatic carcinoma.

Entities:  

Year:  1998        PMID: 11819329      PMCID: PMC4767735          DOI: 10.3748/wjg.v4.i5.392

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

Authors:  G KLATSKIN
Journal:  Am J Med       Date:  1965-02       Impact factor: 4.965

2.  HEPATIC CLONORCHIASIS AND CARCINOMA OF THE BILE DUCT IN A DOG.

Authors:  H P CHANG
Journal:  J Pathol Bacteriol       Date:  1965-01

3.  The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis.

Authors:  P C HOU
Journal:  J Pathol Bacteriol       Date:  1956-07

4.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Authors:  C M Kim; K Koike; I Saito; T Miyamura; G Jay
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

Review 5.  Hepatitis B virus and primary hepatocellular carcinoma.

Authors:  W T London; K Buetow
Journal:  Cancer Invest       Date:  1988       Impact factor: 2.176

6.  The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis.

Authors:  P Zahm; P H Hofschneider; R Koshy
Journal:  Oncogene       Date:  1988-08       Impact factor: 9.867

Review 7.  Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Authors:  R P Beasley
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

8.  Oral contraceptives and cholangiocarcinoma.

Authors:  E F Ellis; P R Gordon; L S Gottlieb
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

9.  A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading.

Authors:  T Nakajima; Y Kondo; M Miyazaki; K Okui
Journal:  Hum Pathol       Date:  1988-10       Impact factor: 3.466

10.  Common evolutionary origin of hepatitis B virus and retroviruses.

Authors:  R H Miller; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

  10 in total
  10 in total

1.  The cloning of 3'-truncated preS/S gene from HBV genomic DNA and its expression in transgenic mice.

Authors:  Yi-Ping Hu; Yu-Cheng Yao; Jian-Xiu Li; Xin-Min Wang; Hong Li; Zhong-Hua Wang; Zhang-Heng Lei
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.

Authors:  Qing-He Nie; Yong-Qian Cheng; Yu-Mei Xie; Yong-Xing Zhou; Xian-Guang Bai; Yi-Zhan Cao
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

3.  Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes.

Authors:  Sheng-Quan Zou; Zhen-Liang Qu; Zhan-Fei Li; Xin Wang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

4.  Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.

Authors:  Xiao-Zhong Wang; Xiao-Chun Chen; Yun-Xin Chen; Li-Juan Zhang; Dan Li; Feng-Lin Chen; Zhi-Xin Chen; Hong-Ying Chen; Qi-Ming Tao
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 5.  Hepatitis B virus infection and intrahepatic cholangiocarcinoma.

Authors:  Hua-Bang Zhou; Jing-Yi Hu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

6.  A potential association between exposure to hepatitis B virus and small bowel adenocarcinoma.

Authors:  Ersilia M DeFilippis; Mamta Mehta; Emmy Ludwig
Journal:  J Gastrointest Oncol       Date:  2016-06

7.  Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A hospital-based, case-control study (SIGES).

Authors:  Hui Wang; Xin-Zu Chen; Xiao-Long Chen; Wei-Han Zhang; Kai Liu; You-Juan Wang; Huai-Rong Tang; Jian-Kun Hu
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

Review 8.  Hepatitis B and C virus infections and the risk of biliary tract cancers: a meta-analysis of observational studies.

Authors:  Yizhou Wang; Ye Yuan; Dongqing Gu
Journal:  Infect Agent Cancer       Date:  2022-08-27       Impact factor: 3.698

9.  Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis.

Authors:  Yanming Zhou; Yanfang Zhao; Bin Li; Jiyi Huang; Lupeng Wu; Donghui Xu; Jiamei Yang; Jia He
Journal:  BMC Cancer       Date:  2012-07-16       Impact factor: 4.430

10.  Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus.

Authors:  M Tanaka; H Tanaka; H Tsukuma; A Ioka; A Oshima; T Nakahara
Journal:  J Viral Hepat       Date:  2010-10       Impact factor: 3.728

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.